Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1980-01-14
1982-09-14
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544313, 544311, C07D23930
Patent
active
043495524
ABSTRACT:
A compound of the formula: ##STR1## wherein R is a bridged alicyclic group selected from the group consisting of norbornyl, norbornenyl, bicyclo[2,2,2]-heptyl and adamantyl optionally substituted by at least one substituent selected from the group consisting of lower alkyl, carboxy, lower alkoxycarbonyl, alkylidenedioxy, N,N-di(lower)alkylcarbamoyl, amino, loweralkoxycarbonylamino and halogen. The present compound is useful in the therapeutic treatment of cancer in human beings and animals.
REFERENCES:
patent: 3971784 (1976-07-01), Tada
patent: 4032524 (1977-06-01), Ozaki et al.
patent: 4071519 (1978-01-01), Ozaki
patent: 4088646 (1972-05-01), Ishida et al.
CA vol. 88, No. 3, p. 644 22966p (1972).
Takaya Takao
Tozuka Zenzaburo
Fujisawa Pharmaceutical Company, Ltd.
Rizzo Nicholas S.
LandOfFree
5-Fluorouracil derivatives, and their pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-Fluorouracil derivatives, and their pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Fluorouracil derivatives, and their pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2154830